Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Summary: "The CLEVER Trial - Targeting Disseminated Dormant Tumor Cells With Hydroxychloroquine, Everolimus, or the Combination to Prevent Recurrent BC"

0 views
November 10, 2023
Comments 0
Login to view comments. Click here to Login